BOMATAK C MINERALISED
Country: New Zealand
Language: English
Source: Ministry for Primary Industries
Summary of Product characteristics
(SPC)
01-07-2018
Public Assessment Report
(PAR)
01-07-2018
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
ethylenediamine dihydroiodide; sodium selenate; disodium cobalt edta; copper disodium edta; oxfendazole; disodium zinc edta
Available from:
Elanco New Zealand
INN (International Name):
ethylenediamine dihydroiodide, oxfendazole, disodium zinc edta, copper disodium edta, disodium cobalt edta, sodium selenate
Composition:
ethylenediamine dihydroiodide 0.95 g/litre; sodium selenate 4.8 g/litre; disodium cobalt edta 1.85 g/litre; copper disodium edta 17.85 g/litre; oxfendazole 90.6 g/litre; disodium zinc edta 8.92 g/litre
Therapeutic area:
Oral nutrient/electrolyte
Authorization status:
ACVM Registered
Authorization date:
1997-06-25
